Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Dhanunjaya Lakkireddy Added: 1 year ago
AHA Conference 2024 - Five-Year safety and efficacy follow-up outcomes investigating the non-inferiority of the AMPLATZER Amulet device (Abbott Medical Devices) against the commercially available WATCHMAN (Boston Scientific) device.Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute - HCA Midwest, KS, US) joins us onsite at AHA Conference to discuss the findings from Amulet IDE … View more
Author(s): Devi Nair Added: 2 months ago
AF Symposium 2026 - Dr Devi Nair (St Bernards Heart & Vascular, US) joins us to discuss early outcomes from the VERITAS Study, evaluating Abbott's next-generation Amulet 360™ Left Atrial Appendage Occluder for stroke prevention in patients with non-valvular atrial fibrillation.This pivotal study enrolled 400 patients across 34 centers in the United States, Canada, and Europe. Findings presented… View more
Author(s): Sarosh Khan , John Davies Added: 3 weeks ago
American College of Cardiology Congress 2026 - Dr Sarosh Khan and Dr John Davies (Essex Cardiothoracic Centre, Basildon, UK) join us to discuss results from the ORBITA-CTO trial (NCT05142215; Mid and South Essex NHS Foundation Trust), a randomised, placebo-controlled study evaluating CTO PCI versus placebo for the relief of stable angina.This double-blind, randomised, placebo-controlled pilot… View more
Author(s): Saibal Kar , Harriette Van Spall Added: 4 weeks ago
ACC.26 – Late-breaker host Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Saibal Kar, MD (Los Robles Regional Medical Center, US) to discuss CHAMPION‑AF (NCT04394546), a global randomized trial comparing the WATCHMAN FLX left atrial appendage closure device with non–vitamin K oral anticoagulants in patients with non‑valvular atrial fibrillation at elevated stroke risk… View more
Author(s): Oussama M Wazni Added: 1 year ago
AHA Conference 2024 - Safety and efficacy outcomes comparing left atrial appendage (LAA) closure with the WATCHMAN FLX device to oral anticoagulation (OAC) following atrial fibrillation (AF) catheter ablation.Dr Oussama Wazni (The Cleveland Clinic Foundation, Ohio, US) joins us onsite at AHA Conference to discuss the findings from OPTION (NCT03795298).OPTION is a prospective, multi-center, multi… View more
Job title: Consultant Cardiologist
Dr Colum Owens, MBBCH is a Consultant Cardiologist at Belfast Health & Social Care Trust. His research interests are Cardiology, Transcatheter Valve Intervention, Patent Foramen Ovale, Left Atrial Appendage Occlusion, Congenital Heart Disease. View more
Job title: Director of the Structural Heart Program
Dr Fadi J Sawaya isDirector of the Structural Heart Program at theAmerican University of Beirut Medical Center, Beirut, Lebanon. His research interests include transcatheter aortic valve implantation (TAVI), left atrial appendage occlusion (LAAC), paravalvular leak closure (PVL), and the treatment of structural heart diseases. Dr Sawaya is an editorial board member ofInterventional Cardiology:… View more
Added: 1 year ago
Parasternal long axis (PLAX) transthoracic echo view: PLAX view showing the mobile mass protruding through the mitral valve with near complete left atrial cavity obliteration. View more
Job title: Cardiologist
Dr Walid Saliba is a Cardiologist in the Department of Cardiovascular Medicine at the Cleveland Clinic in Ohio. At the same institution he serves as the director of the Atrial Fibrillation Center and Director of the Electrophysiology Lab.Dr Saliba achieved both his Physics and Medical Degree at the American University of Beirut. Following his university education, he completed a Cardiology… View more